Susceptibility-guided Bismuth Quadruple Therapy for Multiple-resistant Helicobacter Pylori Strains

NCT06687473 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Pylori
Drug Resistance, Multiple
Virulence Factor

Interventions

DRUG: Bismuth-based susceptibility-guided treatment

Sponsor

National Cheng-Kung University Hospital